Quote:

---

So, here's where I think about the oddity that CYDY recently scrubbed its HIV and other non oncology indications from its website (together with the disappearance of Dr Melissa Palmer). Could it be that, knowing partnership negotiations had failed, CYDY has sold most or all of its non oncology Leronlimab pipeline to Vivi or some other usual suspect? That would likely give CYDY the cash to go it alone, without another debilitating and dilutive cash raise, and mine all of LL's vast potential in oncology. (

---

The entire post seems like very subtle satire. If not, then that scenario is impossible because there are no SEC filings.